Page last updated: 2024-12-06

pentaethylenehexamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Pentaethylenehexamine (PEHA) is a polyamine compound with the formula (CH2CH2NH)6. It is a colorless, viscous liquid that is soluble in water and organic solvents. PEHA is used as a corrosion inhibitor, a chelating agent, and a precursor to other chemicals. It is synthesized by the reaction of ethylene diamine with formaldehyde. PEHA's ability to form stable complexes with metal ions makes it an effective chelating agent. This property is exploited in various applications, such as water treatment, where it can remove heavy metals and prevent scale formation. PEHA also exhibits corrosion inhibition properties, which are attributed to its ability to form a protective layer on metal surfaces. It is used in various industrial applications, including oil and gas production, where it helps to prevent corrosion in pipelines and equipment. PEHA is also a precursor to other important chemicals, such as polymers and resins. Research on PEHA focuses on understanding its properties and exploring new applications. For instance, its effectiveness in removing heavy metals from wastewater and its potential use in the development of new materials is under investigation. '

Cross-References

ID SourceID
PubMed CID19990
CHEMBL ID65184
SCHEMBL ID26707
MeSH IDM0098006

Synonyms (33)

Synonym
einecs 223-775-9
3,6,9,12-tetraazatetradecamethylenediamine
ccris 6264
brn 1768042
4067-16-7
n'-[2-[2-[2-(2-aminoethylamino)ethylamino]ethylamino]ethyl]ethane-1,2-diamine
peha
pentaethylenehexamine
pentaethylenehexamine, technical grade
3,6,9,12-tetraazatetradecane-1,14-diamine
CHEMBL65184
P0622
ec 223-775-9
unii-9k5vzu43le
9k5vzu43le ,
FT-0635115
SCHEMBL26707
pentaethylene hexamine
n1,n1'-(ethane-1,2-diyl)bis(n2-(2-aminoethyl)ethane-1,2-diamine)
pentaethylenexamine
1,4,7,10,13,16-hexaazahexadecane
1,2-bis((2-((2-aminoethyl)amino)ethyl)amino)ethane
W-109943
AKOS024462522
DTXSID7025843
mfcd00008167
CS-0204472
STR02872
Q27272660
A873254
pentaethylenehexamide;3,6,9,12-tetraazatetradecane-1,14-diamine
F87473
pentaethylenehexamine, tech grade
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID91436Inhibition against HIV-1 integrase at 200 uM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID91435Inhibition against HIV-1 integrase at 1 mM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.25)18.7374
1990's2 (12.50)18.2507
2000's4 (25.00)29.6817
2010's6 (37.50)24.3611
2020's3 (18.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.55 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]